Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

Nature Medicine
Hao WuFredrik Bäckhed

Abstract

Metformin is widely used in the treatment of type 2 diabetes (T2D), but its mechanism of action is poorly defined. Recent evidence implicates the gut microbiota as a site of metformin action. In a double-blind study, we randomized individuals with treatment-naive T2D to placebo or metformin for 4 months and showed that metformin had strong effects on the gut microbiome. These results were verified in a subset of the placebo group that switched to metformin 6 months after the start of the trial. Transfer of fecal samples (obtained before and 4 months after treatment) from metformin-treated donors to germ-free mice showed that glucose tolerance was improved in mice that received metformin-altered microbiota. By directly investigating metformin-microbiota interactions in a gut simulator, we showed that metformin affected pathways with common biological functions in species from two different phyla, and many of the metformin-regulated genes in these species encoded metalloproteins or metal transporters. Our findings provide support for the notion that altered gut microbiota mediates some of metformin's antidiabetic effects.

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Aug 14, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·J H ScarpelloH C Howlett
Dec 11, 1999·Nucleic Acids Research·M Kanehisa, S Goto
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Jul 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David StepenskyAmnon Hoffman
Apr 25, 2006·Journal of Clinical Gastroenterology·Julia M W WongDavid J A Jenkins
Jan 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Apr 5, 2007·Nature Protocols·Erwin G ZoetendalWillem M de Vos
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Feb 6, 2010·Genome Biology·Matthew D YoungAlicia Oshlack
May 17, 2011·International Journal of Systematic and Evolutionary Microbiology·Seong-Kyu ParkJin-Woo Bae
Mar 6, 2012·Nature Methods·Ben Langmead, Steven L Salzberg
Apr 12, 2012·Diabetes·Lisa LogieGraham Rena
Dec 4, 2012·Nucleic Acids Research·Andrea FranceschiniLars J Jensen
Feb 21, 2013·Nutrition Journal·Jesús VioqueUNKNOWN INMA-Valencia Cohort Study
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amandine EverardPatrice D Cani
May 31, 2013·Nature·Fredrik H KarlssonFredrik Bäckhed
Aug 29, 2013·Nature Reviews. Gastroenterology & Hepatology·Frank G SchaapPeter L M Jansen
Aug 30, 2013·Nature·Aurélie CotillardStanislav Dusko Ehrlich
Nov 19, 2013·Cell Host & Microbe·Anita WichmannFredrik Bäckhed
Dec 10, 2013·Nucleic Acids Research·Tatiana TatusovaIgor Tolstoy
Jan 8, 2014·Nature Reviews. Endocrinology·Ida Pernicova, Márta Korbonits
Apr 16, 2014·The Lancet. Diabetes & Endocrinology·José Manuel Fernández-Real, Melania Manco
Jun 16, 2014·Bioinformatics·Zuguang GuBenedikt Brors
Jul 7, 2014·Nature Biotechnology·Junhua LiUNKNOWN MetaHIT Consortium
Jul 11, 2014·PLoS Computational Biology·Fredrik H KarlssonJens Nielsen
Jul 20, 2014·Applied and Environmental Microbiology·Heetae Lee, GwangPyo Ko
Sep 13, 2014·The ISME Journal·Husen ZhangXin M Luo
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders

❮ Previous
Next ❯

Citations

Jul 18, 2017·International Journal of Molecular Sciences·Paola Dongiovanni, Luca Valenti
Dec 6, 2017·Alimentary Pharmacology & Therapeutics·Q Le BastardE Montassier
Mar 3, 2018·Advances in Therapy·Bruno K Rodiño-JaneiroJavier Santos
Oct 5, 2017·Genes·Sophie A Montandon, François R Jornayvaz
Dec 30, 2017·Genes·Silke Crommen, Marie-Christine Simon
Feb 27, 2018·Current Hypertension Reports·Mohammad G Saklayen
Jan 9, 2018·Endocrine Reviews·Abraham S MeijnikmanHilde Herrema
Dec 13, 2017·European Journal of Immunology·Stefanie Ascher, Christoph Reinhardt
Dec 23, 2017·Diabetes/metabolism Research and Reviews·Faiza MalikJesse Roth
May 1, 2018·Protein & Cell·Marwah DoestzadaJingyuan Fu
Mar 25, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Cyrielle CaussyUNKNOWN Genetics of NAFLD in Twins Consortium
Sep 8, 2017·Expert Review of Clinical Pharmacology·André J Scheen
Apr 11, 2018·Current Opinion in Clinical Nutrition and Metabolic Care·Julie RodriguezNathalie M Delzenne
May 20, 2018·Journal of Diabetes Investigation·Takahiro MinamiiWataru Ogawa
May 5, 2018·Environmental Microbiology·Antoine Danchin
Apr 25, 2018·Journal of Neurogastroenterology and Motility·Fanny Giron, Eamonn M M Quigley
Mar 21, 2018·MSystems·Peter J Turnbaugh
Oct 18, 2018·Current Diabetes Reports·Petter Bjornstad, Robert H Eckel
Nov 14, 2018·Future Microbiology·Sarah CourtoisEmilie Bessède
Nov 7, 2018·Nature Medicine·Lulu SunChangtao Jiang
Jun 15, 2018·Gut·Judith Aron-WisnewskyKarine Clément
Nov 23, 2018·Drug Delivery and Translational Research·Suping WangHockin H K Xu
Dec 26, 2018·International Journal of Molecular Sciences·Raphaëlle CorremansAnja Verhulst
Jan 31, 2018·Diabetologia·Kristine H AllinOluf Pedersen
Oct 16, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zydrune Polianskyte-PrauseSanna Lehtonen
Jan 23, 2019·Molecular Nutrition & Food Research·Xiaojun LiJinyou Duan
Feb 12, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Yong LiWeimin Li
Mar 25, 2019·Hypertension·Hendrik BartolomaeusDominik N Muller
Apr 3, 2019·Clinical Pharmacology and Therapeutics·Anukriti SharmaJack A Gilbert
Jun 3, 2017·Nature Reviews. Endocrinology·Conor A Bradley
May 10, 2019·Risk Analysis : an Official Publication of the Society for Risk Analysis·Joseph RodricksPamela Shubat
Jun 1, 2017·Nature Reviews. Gastroenterology & Hepatology·Conor A Bradley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.